The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Radical prostatectomy as a component of multimodal therapy for highly selected M1 prostate cancer patients.
 
Matthew O'Shaughnessy
No Relationships to Disclose
 
James Andrew Eastham
No Relationships to Disclose
 
Bernard H. Bochner
No Relationships to Disclose
 
Vincent Paul Laudone
No Relationships to Disclose
 
Brett Stewart Carver
No Relationships to Disclose
 
Daniel Sjoberg
No Relationships to Disclose
 
Peter T. Scardino
No Relationships to Disclose
 
Howard I. Scher
Honoraria - Chugai Pharma
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Celgene; Endo Pharmaceuticals; Endocyte; Exelixis; Ferring; Foundation Medicine; Genentech; Janssen; Medivation; OncologySTAT; Palmetto GBA; Pfizer; Sanofi; Takeda; Ventana Medical Systems; WIRB-Copernicus Group
Speakers' Bureau - WebMD
Research Funding - BIND Biosciences (Inst); Epic Sciences (Inst); Exelixis (Inst); Guardant Health (Inst); Janssen (Inst); Janssen Diagnostics (Inst); Medivation (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Celgene; Endocyte; Exelixis; Ferring; Genentech; Janssen; Pfizer; Sanofi; Takeda; WIRB-Copernicus Group
 
Karim A. Touijer
No Relationships to Disclose